Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Cyclooxygenase-2 in glioblastoma multiforme.

Qiu J, Shi Z, Jiang J.

Drug Discov Today. 2017 Jan;22(1):148-156. doi: 10.1016/j.drudis.2016.09.017. Review.

PMID:
27693715
2.

Defining the therapeutic time window for suppressing the inflammatory prostaglandin E2 signaling after status epilepticus.

Du Y, Kemper T, Qiu J, Jiang J.

Expert Rev Neurother. 2016;16(2):123-30. doi: 10.1586/14737175.2016.1134322. Review.

3.

Therapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticus.

Jiang J, Yang MS, Quan Y, Gueorguieva P, Ganesh T, Dingledine R.

Neurobiol Dis. 2015 Apr;76:126-36. doi: 10.1016/j.nbd.2014.12.032.

4.

Role of inflammatory mediators in the pathogenesis of epilepsy.

Shimada T, Takemiya T, Sugiura H, Yamagata K.

Mediators Inflamm. 2014;2014:901902. doi: 10.1155/2014/901902. Review.

5.

When and how do seizures kill neurons, and is cell death relevant to epileptogenesis?

Dingledine R, Varvel NH, Dudek FE.

Adv Exp Med Biol. 2014;813:109-22. doi: 10.1007/978-94-017-8914-1_9. Review.

6.

Cyclooxygenase-2 in epilepsy.

Rojas A, Jiang J, Ganesh T, Yang MS, Lelutiu N, Gueorguieva P, Dingledine R.

Epilepsia. 2014 Jan;55(1):17-25. doi: 10.1111/epi.12461. Review.

7.

Allele-specific programming of Npy and epigenetic effects of physical activity in a genetic model of depression.

Melas PA, Lennartsson A, Vakifahmetoglu-Norberg H, Wei Y, Åberg E, Werme M, Rogdaki M, Mannervik M, Wegener G, Brené S, Mathé AA, Lavebratt C.

Transl Psychiatry. 2013 May 7;3:e255. doi: 10.1038/tp.2013.31.

8.
9.

The role of inflammation in epileptogenesis.

Vezzani A, Friedman A, Dingledine RJ.

Neuropharmacology. 2013 Jun;69:16-24. doi: 10.1016/j.neuropharm.2012.04.004. Review.

10.

Bilateral common carotid artery ligation transiently changes brain lipid metabolism in rats.

Bhattacharjee AK, White L, Chang L, Ma K, Harry GJ, Deutsch J, Rapoport SI.

Neurochem Res. 2012 Jul;37(7):1490-8. doi: 10.1007/s11064-012-0740-2.

11.

Superior Neuroprotective Efficacy of LAU-0901, a Novel Platelet-Activating Factor Antagonist, in Experimental Stroke.

Belayev L, Eady TN, Khoutorova L, Atkins KD, Obenaus A, Cordoba M, Vaquero JJ, Alvarez-Builla J, Bazan NG.

Transl Stroke Res. 2012 Mar;3(1):154-63. doi: 10.1007/s12975-011-0116-y.

12.

Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2.

Jiang J, Ganesh T, Du Y, Quan Y, Serrano G, Qui M, Speigel I, Rojas A, Lelutiu N, Dingledine R.

Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3149-54. doi: 10.1073/pnas.1120195109.

13.

Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus.

Serrano GE, Lelutiu N, Rojas A, Cochi S, Shaw R, Makinson CD, Wang D, FitzGerald GA, Dingledine R.

J Neurosci. 2011 Oct 19;31(42):14850-60. doi: 10.1523/JNEUROSCI.3922-11.2011.

14.

Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor.

Jiang J, Ganesh T, Du Y, Thepchatri P, Rojas A, Lewis I, Kurtkaya S, Li L, Qui M, Serrano G, Shaw R, Sun A, Dingledine R.

Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2307-12. doi: 10.1073/pnas.0909310107.

15.

Docosahexaenoic acid neurolipidomics.

Niemoller TD, Bazan NG.

Prostaglandins Other Lipid Mediat. 2010 Apr;91(3-4):85-9. doi: 10.1016/j.prostaglandins.2009.09.005. Review.

16.
17.

Cyclooxygenase-2-specific inhibitor improves functional outcomes, provides neuroprotection, and reduces inflammation in a rat model of traumatic brain injury.

Gopez JJ, Yue H, Vasudevan R, Malik AS, Fogelsanger LN, Lewis S, Panikashvili D, Shohami E, Jansen SA, Narayan RK, Strauss KI.

Neurosurgery. 2005 Mar;56(3):590-604.

18.
19.

Aspirin and other anti-inflammatory drugs.

Vane SJ.

Thorax. 2000 Oct;55 Suppl 2:S3-9. Review. No abstract available.

20.

Prolonged cyclooxygenase-2 induction in neurons and glia following traumatic brain injury in the rat.

Strauss KI, Barbe MF, Marshall RM, Raghupathi R, Mehta S, Narayan RK.

J Neurotrauma. 2000 Aug;17(8):695-711. Erratum in: J Neurotrauma 2000 Nov;17(11):1115.

Items per page

Supplemental Content

Support Center